Bafilomycin-like metabolite from a novel Micromonospora species

Details for Australian Patent Application No. 2003251730 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Laakso, Jodi Ann; Van Dun, Jacobus Alphonsus Josephus; Janicot, Michel Marie Francois; Wouters, Walter Boudewijn Leopold; Mocek, Ursula Maria

Agent Shelston IP

Pub. Number AU-B-2003251730

PCT Number PCT/EP03/50276

PCT Pub. Number WO2004/005311

Priority 60/393,149 02.07.02 US

Filing date 30 June 2003

Wipo publication date 23 January 2004

Acceptance publication date 30 April 2009

International Classifications

C12P 17/16 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - containing two or more hetero rings

A61K 31/365 (2006.01) - Lactones

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7048 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07D 313/00 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

C07H 7/06 (2006.01) Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond

C07H 17/04 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12P 17/14 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

C12R 1/29 (2006.01)

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 60/393,149 02.07.02 US

11 March 2004 Application Open to Public Inspection

  Published as AU-B-2003251730

30 April 2009 Application Accepted

  Published as AU-B-2003251730

27 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003251731-New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance

2003251729-USE OF ANTIBODIES AGAINST FLT-1 FOR THE TREATMENT OF OSTEOPOROSIS